Zoltan A Tokes

Title: Zoltan A Tokes: Innovator in Cardiac Risk Assessment and Drug Delivery

Introduction

Zoltan A Tokes is a notable inventor based in Los Angeles, CA. He has made significant contributions to the fields of cardiac risk assessment and drug delivery systems. With a total of 2 patents, his work has the potential to impact patient care and treatment methodologies.

Latest Patents

One of Tokes' latest patents is a method and means for assessment and prediction of the risk of subsequent cardiac ischemic events. This innovative approach involves monitoring levels of acid glycoprotein and CK-MB relative to predetermined threshold levels after a sentinel event. By correlating these monitored levels with the predicted likelihood of future cardiac ischemic events, this method classifies patients into categories of risk.

Another significant patent focuses on drug delivery by polymeric carriers. In this invention, anthracycline cancer drugs are covalently coupled to polymeric particles, enhancing their cytostatic activity. This coupling not only increases the effectiveness against cancer cells but also allows the bound drug to retain its activity after repeated uses, showing promise against drug-resistant cells.

Career Highlights

Throughout his career, Zoltan A Tokes has worked with esteemed organizations such as the University of Southern California and Immudx, Inc. His experience in these institutions has contributed to his expertise in the medical and pharmaceutical fields.

Collaborations

Tokes has collaborated with notable coworkers, including Kathryn E Rogers and Alan Rembaum. These partnerships have likely enriched his research and development efforts.

Conclusion

Zoltan A Tokes stands out as an innovator whose patents in cardiac risk assessment and drug delivery systems reflect his commitment to advancing medical science. His contributions have the potential to improve patient outcomes significantly.